{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:52:37Z","timestamp":1789707157702,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.eplepsyres.2025.107507","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T04:45:31Z","timestamp":1736397931000},"page":"107507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Use of benzodiazepines in patients with status epilepticus requiring second-line antiseizure medication treatment"],"prefix":"10.1016","volume":"210","author":[{"given":"Teemu","family":"P\u00f6yt\u00e4kangas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2239-7681","authenticated-orcid":false,"given":"Pabitra","family":"Basnyat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirpa","family":"Rainesalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Peltola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka T.","family":"Saarinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2025.107507_bib1","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/epi.13056","article-title":"Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: a multicenter comparison","volume":"56","author":"Alvarez","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107507_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0920-1211(91)90011-4","article-title":"A comparative pharmacokinetic study of intravenous and intramuscular midazolam in patients with epilepsy","volume":"10","author":"Bell","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2025.107507_bib3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/bja\/79.5.575","article-title":"Pharmacokinetics of midazolam given as an intranasal spray to adult surgical patients","volume":"79","author":"Bj\u00f6rkman","year":"1997","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.eplepsyres.2025.107507_bib4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jns.2017.09.031","article-title":"Impact of non-guideline-based treatment of status epilepticus","volume":"382","author":"Braun","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.eplepsyres.2025.107507_bib5","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","article-title":"Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial","volume":"395","author":"Chamberlain","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2025.107507_bib6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3109\/10903127.2014.959220","article-title":"Parenteral midazolam is superior to diazepam for treatment of prehospital seizures","volume":"19","author":"Clemency","year":"2015","journal-title":"Prehosp. Emerg. Care"},{"key":"10.1016\/j.eplepsyres.2025.107507_bib7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1212\/WNL.55.5.693","article-title":"Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR)","volume":"55","author":"Coeytaux","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2025.107507_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American epilepsy society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.eplepsyres.2025.107507_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/ane.13363","article-title":"Therapy delay in status epilepticus extends its duration and worsens its prognosis","volume":"143","author":"Guti\u00e9rrez-Viedma","year":"2021","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2025.107507_bib10","first-page":"1385","article-title":"Update on current care guideline: status epilepticus","volume":"132","author":"K\u00e4lvi\u00e4inen","year":"2016","journal-title":"Duodecim"},{"key":"10.1016\/j.eplepsyres.2025.107507_bib11","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1111\/ene.15800","article-title":"Burden of suspected epileptic seizures on emergency services: a population-based study","volume":"30","author":"K\u00e4mppi","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107507_bib12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1046\/j.1528-1157.2001.01101.x","article-title":"Incidence of status epilepticus in adults in Germany: a prospective, population-based study","volume":"42","author":"Knake","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107507_bib13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1468-1331.2009.02917.x","article-title":"EFNS guideline on the management of status epilepticus in adults","volume":"17","author":"Meierkord","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107507_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2010.169","article-title":"Frequency and prognosis of convulsive status epilepticus of different causes: a systematic review","volume":"67","author":"Neligan","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107507_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2023.107218","article-title":"Indications for the use of intravenous second-line antiseizure medications in an emergency room setting","volume":"196","author":"P\u00f6yt\u00e4kangas","year":"2023","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2025.107507_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1684\/epd.2018.0987","article-title":"Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus","volume":"20","author":"Rao","year":"2018","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.eplepsyres.2025.107507_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117542","article-title":"Status epilepticus: practice variation and adherence to treatment guideline in a large community hospital","volume":"427","author":"Sairanen","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.eplepsyres.2025.107507_bib18","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/acem.13811","article-title":"Underdosing of benzodiazepines in patients with status epilepticus enrolled in established status epilepticus treatment trial","volume":"26","author":"Sathe","year":"2019","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.eplepsyres.2025.107507_bib19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/epi.16825","article-title":"Patterns of benzodiazepine underdosing in the established status epilepticus treatment trial","volume":"62","author":"Sathe","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107507_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2125.1998.00781.x","article-title":"Midazolam pharmacokinetics following intravenous and buccal administration","volume":"46","author":"Schwagmeier","year":"1998","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2025.107507_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.seizure.2019.10.003","article-title":"What is status epilepticus and what do we know about its epidemiology?","volume":"75","author":"Shorvon","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2025.107507_bib22","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus \u2013 Report of the ILAE task force on classification of status epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107507_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.seizure.2016.11.001","article-title":"25 years of advances in the definition, classification and treatment of status epilepticus","volume":"44","author":"Trinka","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2025.107507_bib24","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000010828","article-title":"First-line medication dosing in pediatric refractory status epilepticus","volume":"95","author":"Vasquez","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2025.107507_bib25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ajem.2021.01.094","article-title":"Assessment of benzodiazepine dosing strategies for the management of status epilepticus in the emergency department","volume":"44","author":"Weant","year":"2021","journal-title":"Am. J. Emerg. Med."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121125000087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121125000087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T21:26:45Z","timestamp":1739914005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121125000087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":25,"alternative-id":["S0920121125000087"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107507","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of benzodiazepines in patients with status epilepticus requiring second-line antiseizure medication treatment","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107507"}}